New in silico models for cardiac safety in drugs

One of the most frequent debates in the scientific community today regards how to reduce the risk of drug-induced cardiac safety issues in drugs. CardiacSafety is crucial in the development of new molecules, since drugs can sometimes interfere with the … Read More